@WHO: "These drugs were chosen by an independent panel of experts that evaluates all the available evidence on all potential therapeutics. The [Solidarity PLUS] trial involves thousands of researchers at 600+ hospitals in 52 countries"-@DrTedros #COVID19 https://t.co/XOhuGPyaGK

http://twitter.com/WHO
via IFTTT